The stock market has a secret weapon that's powering record highs
Earnings revisions breadth has improved, driven by more positive analyst estimates.
The S&P 500 expected to reach 6,500, aided by earnings growth and a weaker dollar.
The stock market has made an impressive recovery from its April low, and Morgan Stanley sees one strong sign that the gains are set to continue.
With trade concerns and geopolitical conflicts easing, the market made new highs again on Monday, adding to gains amid fresh progress on trade.
S&P 500: 6,190.75, up 0.23%
Dow Jones Industrial Average: 44,027.87, up 0.37% (+160.76 points)
Nasdaq Composite: 20,338.95, up 0.25%
As headwinds from earlier this year, such as tariffs and fears of an AI spending slowdown, begin to ease, a key source of strength for the stock market has rebounded
Earnings revisions breadth, or the proportion of analysts who have raised their estimates minus the proportion who have lowered them, has improved significantly in the past few months.
In April, Bloomberg Intelligence data found that estimates for earnings-per-share growth had fallen from 11.4% to 6.9% since the beginning of 2025.
At the April bottom, earnings revision breadth stood at -25%. It's since improved to -5%, and its recovery has been swift. Earlier in June, earnings revisions breadth was at -10%.
Going forward, Morgan Stanley anticipates a bullish rate of change on EPS revisions to be a key factor in further stock market gains, especially as earnings revisions breadth ticks closer to a positive number.
"On that score, specifically, the message is crystal clear. The ERB bottomed on April 17th around MSFT's earnings report and has not looked back since," Morgan Stanley analysts led by chief investment officer Mike Wilson wrote. "As we have noted for the past couple of months, the recovery in this metric has been more about positive revisions rather than fewer negative ones and when that is the case, the forward equity market returns tend to be stronger,"
More upward revisions have typically led to 12% S&P 500 stock gains in the next 12 months, while fewer negative revisions have led to only 8% gains over the same time period, they added.
Morgan Stanley expects the S&P 500 to end the year at 6,500, implying a gain of about 5% from current record levels. With analysts growing more bullish on corporate earnings, the outlook points to a potentially sustainable growth trajectory.
The bank attributes the plunge in earnings estimates earlier this year largely to perceived weakness in the Magnificent Seven stocks. But now, earnings growth is on track to outperform overall economic growth, something that wasn't the case in the 2022 to 2024 bull market.
The bank expects a weaker dollar and tax incentives from the Big Beautiful Bill to continue encouraging positive earnings outlooks, and also contribute to a broadening market.
"As we head into the second half of the year, the equity market is likely to be driven by more bullish rate of change on EPS revisions, monetary policy expectations, and back-end rates/term premium," Mike Wilson, the bank's chief equity strategist, wrote. "This is a notably different environment than large parts of 2023-2024 when prospects of easier monetary and fiscal policy drove markets higher despite stagnating EPS revisions."
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 minutes ago
- Yahoo
Breaking: Dow Hits Record High as Wall Street Banks on Rate Cuts and Trade Wins
Aug 15 - The Dow Jones Industrial Average briefly touched a new intraday record on Friday, completing the trio of major U.S. indexes reaching fresh highs amid hopes of easier monetary policy, progress on trade deals, and strong corporate earnings. The Dow rose 0.3% to 45,062 points, propelled by a 9.5% surge in UnitedHealth Group (NYSE:UNH) shares after Warren Buffett (Trades, Portfolio)'s Berkshire Hathaway revealed a new stake. Warning! GuruFocus has detected 5 Warning Sign with UNH. List of 52-Week Lows List of 3-Year Lows List of 5-Year Lows Blue-chip heavyweights including Goldman Sachs (NYSE:GS), Microsoft (NASDAQ:MSFT), and Caterpillar (NYSE:CAT) drove the index's climb, while Nvidia (NASDAQ:NVDA) also supported gains with its year-to-date surge above 30%. Despite the rally, the Dow lagged the S&P 500 and Nasdaq, which reached record highs in June, due in part to its limited exposure to high-performing AI stocks and mixed results from names like UnitedHealth and Salesforce (NYSE:CRM). According to analysts, the Dow, a historically high value, price-weighted index, has, since its April lows, owing to trade tensions and tariffs-related announcements, returned more than 20%. Hope in the possible trade deals between the U.S. and other nations, a loose labour market, and possible Fed rate decreases have also strengthened investor positioning to an extent, indicating a tentatively optimistic blue-chip stocks position as far as the index on Wall Street is concerned, as it looks toward realizing sustained stability. This article first appeared on GuruFocus. Sign in to access your portfolio
Yahoo
13 minutes ago
- Yahoo
Rupee slips; S&P upgrade lends a lifeline ahead of Trump-Putin meet
By Ashwin Manikandan and Nimesh Vora MUMBAI (Reuters) - The Indian rupee declined on Thursday with traders treading lightly ahead of the Trump-Putin summit, although S&P's upgrade offered a silver lining. The rupee closed at 87.5500 against the U.S. dollar, softer than Wednesday's close of 87.4400, navigating a choppy session that saw it swing between 87.39 and 87.67. With the focus squarely on the Trump-Putin meet, the S&P's upgrade of India offered a boost to the local currency right when it was grappling with midday pressure. S&P noted that India's robust external position is a key credit strength. It highlighted that current account deficits are likely to remain small over the next few years, while domestic demand stabilises and a weaker rupee boosts competitiveness. The agency further pointed to the rupee's active trading status, noting it accounts for more than 1% of global foreign exchange turnover. "In the shorter term, we may see some relief on the ratings upgrade, but the rupee is still not out of the woods as trade uncertainties persist and broad economic indicators are still weak," said Dilip Parmar, currency analyst at HDFC Securities. The Trump-Putin meeting to discuss the Russia-Ukraine war holds added significance for the rupee. The U.S. president has criticised India's purchase of Russian oil and imposed an extra 25% tariff on its goods effective August 27, doubling the rate to 50% - the highest U.S. tariff on a country alongside Brazil. The currency unit touched 87.8850 last week after Trump's tariffs salvo, with the Reserve Bank of India stepping in to prevent the rupee from breaching the all-time low of 87.95 - a level bankers believe the central bank will continue to defend. Meanwhile, the U.S. dollar index was up 0.1% at 97.835 at 1550 IST.


Business Upturn
an hour ago
- Business Upturn
Stocks to watch on August 18: M&M, Ashok Leyland, Tata Chemicals, HDFC Bank, BPCL, Max Healthcare and more
Brokerage houses have released fresh updates and recommendations on key Indian stocks and sectors, which are likely to drive trading action today. Here are the highlights from fund house recommendations. Nomura has maintained a buy rating on Mahindra & Mahindra (M&M) with a target price of ₹3,736 per share, citing strong positioning in the SUV segment. On Ashok Leyland, BofA, Avendus and Motilal Oswal (MOSL) all maintained their buy calls with target prices of ₹146, ₹140, and ₹141 respectively, indicating continued optimism around the commercial vehicle cycle. Jefferies was more conservative, keeping a buy call but with a lower target price of ₹120, reflecting near-term constraints. Morgan Stanley (MS) retained an overweight stance on Tata Chemicals with a target price of ₹1,127, expecting the company to benefit from structural demand drivers. Jefferies reiterated its buy ratings on Aditya Birla Fashion & Retail (target ₹100), HDFC Bank (₹2,400), HDB Financial (₹900), BPCL (raised target ₹410), and Max Healthcare (₹1,500). It also maintained an underperform on Anupam Rasayan despite raising the target price to ₹625. In the financial space, Citi reiterated its buy on Shriram Finance with a target price of ₹750. On the macro front, the India ratings upgrade drew commentary from multiple brokerages. JP Morgan called it 'unambiguously positive' and a likely sentiment booster. Kotak Securities noted that the upgrade reflected fiscal consolidation and growth, though future improvements hinge on state finances. Citi said the earlier-than-expected move may not immediately trigger debt inflows, while UBS highlighted that it takes India one step above the lowest investment-grade and could benefit state-owned enterprises. On GST rate rationalisation, Jefferies expects the government to act in Q4CY25, noting $20 billion in savings from GST compensation provides the fiscal room. It said rate cuts may benefit cement, two-wheelers, consumer durables, insurance, garments, footwear, and passenger vehicles. Kotak estimated the move could deliver a ₹2.4 trillion demand boost, largely aiding autos and durables, while Citi said autos, consumer discretionary, staples, insurance and cement could see the highest impacts. Morgan Stanley added that autos remain key as they account for 14% of GST collections, with Hero, Eicher, Maruti and M&M positioned as beneficiaries. On Indian equities overall, Jefferies called India the best long-term structural story in Asia, while Morgan Stanley noted that thawing India-China ties could revive investments and supply chains. In other stock-specific views, UBS maintained a neutral on Vodafone Idea with a target of ₹8.5, while Citi kept a buy call at ₹10. UBS also maintained a neutral on Angel One (TP ₹2,935). MOSL retained a sell rating on Deepak Nitrite with a cut target of ₹1,630. With strong endorsements for autos, chemicals, financials and healthcare, along with optimism on GST reforms and the sovereign rating outlook, today's trading session is expected to see concentrated action in these names. Disclaimer: The brokerage views and target prices mentioned in this article are sourced directly from fund house and analyst reports. They are presented here for informational and news purposes only. Business Upturn does not provide investment advice or stock recommendations. Readers are advised to consult certified financial advisors before making any investment decisions. Ahmedabad Plane Crash News desk at